Company Filing History:
Years Active: 2022
Title: Duncan McHale: Innovator in Immune Modulation
Introduction
Duncan McHale is a notable inventor based in Kent, GB. He has made significant contributions to the field of immune disorders through his innovative research and development. His work focuses on utilizing immune-modulating bacteria strains as therapeutic agents.
Latest Patents
Duncan McHale holds a patent for "Compositions and methods for treating immune disorders using immune modulating bacteria strains." This patent outlines methods and compositions related to immune-modulating strains that are useful in treating immune disorders. Specifically, it includes methods of administering a bacterial composition comprising Strain A (ATCC Deposit Number PTA-125368) to subjects suffering from immune disorders.
Career Highlights
Duncan McHale is currently associated with Evelo Biosciences, Inc., where he continues to advance his research in immune modulation. His work has the potential to impact the treatment of various immune-related conditions, showcasing his dedication to improving health outcomes.
Collaborations
Duncan collaborates with talented individuals such as Brian Goodman and Holly Ponichtera, who contribute to the innovative environment at Evelo Biosciences, Inc. Their combined expertise fosters a collaborative approach to tackling complex challenges in the field of immunology.
Conclusion
Duncan McHale's contributions to the field of immune modulation through his patent and work at Evelo Biosciences, Inc. highlight his role as an influential inventor. His research has the potential to pave the way for new therapeutic strategies in treating immune disorders.